Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing

  • 20 Accesses

  • 2 Citations

Abstract

The present study investigated the effects of a benzodiazepine receptor antagonist, β-carboline ZK 93426 (1, 3 and 10 mg/kg, IP), on scopolamine and nucleus basalis (NB) quisqualic acid lesion-induced neocortical electrocortical activity slowing in rats. Scopolamine induced a dose dependent increase in EEG spectral values and slow delta waves (0.3<0.9=2.7 mg/kg IP). ZK 93426 partially reversed EEG slowing induced by the smallest scopolamine dose (0.3 mg/kg), but had no effect on the EEG changes induced by higher doses. A combination of scopolamine at 0.3 mg/kg and mecamylamine (a centrally active nicotinic antagonist) at 10 mg/kg induced an EEG slowing that was not reversed by ZK 93426. NB lesions markedly decreased cortical choline acetyltransferase (ChAT) activity (−77%) and increased EEG slow waves. ZK 93426 had no effect on the NB lesion-induced slow wave activity increase. The present results support the idea that β-carboline ZK 93426 may increase cortical cholinergic activity by disinhibiting the NB cholinergic neurons. However, if the activity of “NB to cortex” cholinergic system is greatly decreased by either a marked reduction in NB cell number (in NB-lesioned rats), a near complete cortical post-synaptic muscarinic receptor blockade (large scopolamine dose) or by a combination of nicotinic (decrease acetylcholine release) and muscarinic receptor blockade, the effects of β-carboline ZK 93426 on EEG slowing may be negligible.

This is a preview of subscription content, log in to check access.

References

  1. Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P Sr (1991) Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in Alzheimer's disease. Neurosci Lett 127:113–116

  2. Atweh S, Simon JR, Kuhar MJ (1976) Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. Life Sci 17:1535–1544

  3. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric dysfunction. Science 217:408–417

  4. Beani L, Bianchi C, Ferraro L, Nilsson L, Nordberg A, Romanelli L, Spalluto P, Sundwall A, Tanganelli S (1989) Effects of nicotine on the release of acetylcholine and amino acids in the brain. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Nicotine receptors in the CNS: their role in synaptic transmission. Elsevier, Amsterdam

  5. Becker RE, Giacobini E (1988) Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects. Drug Dev Res 12:163–195

  6. Bigl A, Woolf NJ, Butcher LL (1982) Cholinergic projections from basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res Bull 8:727–749

  7. Bowen DM, Smith CP, White P, Davinson AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiothrophies. Brain 99:459–496

  8. Buzsáki G, Bickford RG, Ponomareff G, Thal LJ, Mandel G, Gage F (1988) Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 11:4007–4026

  9. Casamenti F, Deffenu G, Abbamondi AL, Pepeu G (1986) Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res Bull 16:589–695

  10. Detari L, Vanderwolf CH (1987) Activity of identified cortically projections and other basal forebrain neurons during large slow waves and cortical activation in anesthetized. Brain Res 437:1–10

  11. Halliwell JV (1986) M-current in human neurocortical neurones. Neurosci Lett 67:1–6

  12. Hedreen JC, Bacon SJ and Price DL (1985) A modified histochemical technique to visualize acetylcholinesterase containing axons. J Histochem Cytochem 33:134–140

  13. Hodges H, Trasher S, Gray JA (1989) Improved radial maze performance induced by the benzodiazepine antagonist ZK93426 in lesioned and alcohol treated rats. Behav Pharmacol 1:45–55

  14. Ingham CA, Bolam JP, Smith AD (1988) GABA-immunoreactive synaptic boutons in the rat basal forebrain: comparison of neurons that project to the neocortex with pallidosubthalamic neurons. J Comp Neurol 273:263–282

  15. Madison DV, Lancaster B, Nicoll RA (1987) Voltage clamp analysis of cholinergic action in the hippocampus. J Neurosci 7:733–741

  16. Mazurkiewicz MM, Sirviö J, Riekkinen P (1992) Attenuation by the benzodiazepine receptor antagonist, ZK 93426, of the deficit in spatial navigation induced by nucleus basalis lesions. Behav Neural Biol (in press)

  17. McCormick DA (1989) Cholinergic and noradrenergic modulation of thalamocortical processing. TINS 12:215–221

  18. Miller JA, Chmielewski PA (1990) The regulation of high-affinity choline uptake in vitro in rat cortical and hippocampal synaptosomes byβ-carbolines administered in vivo. Neurosci Lett 114:351–355

  19. Paxinos G and Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York

  20. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet i:289

  21. Reinikainen KJ, Riekkinen PJ, Paljärvi L, Soininen H, Helkala E-L, Jolkkonen J, Laakso M (1989) Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13:135–146

  22. Riekkinen P Jr, Sirviö J, Hannila T, Miettinen T, Riekkinen P (1990a) Effects of quisqualic acid NB lesioning on cortical EEG passive avoiance and water maze performance. Brain Res Bull 24:839–842

  23. Riekkinen P Jr, Sirviö J, Riekkinen P (1990b) Relationship between the cortical ChAT content and EEG delta activity. Neurosci Res 8:12–20

  24. Riekkinen P, Buzsáki G, Riekkinen P Jr, Soininen H, Partanen J, Alhainen K (1991) The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 78:89–96

  25. Riekkinen P Jr, Jäkälä P, Sirviö J, Koivisto E, Miettinen R, Riekkinen P (1991) The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing. Brain Res Bull 26:633–637

  26. Sarter M, Schneider HH (1988) High density of benzodiazepine binding sites in the substantia innominata of the rat. Pharmacol Biochem Behav 30:679–682

  27. Sarter M, Steckler T (1989) Spontaneous exploration of a 6-arm radial tunnel maze by basal forebrain lesioned rats: effects of the benzodiazepine receptor antagonistβ-carboline ZK 93426. Psychopharmacology 98:193–202

  28. Sarter M, Bodewitz G, Stephens DN (1988) Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonistβ-carbolines. Psychopharmacology 94:491–495

  29. Sarter M, Bruno JP, Dudchenko P (1990) Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplication. Psychopharmacology 101:1–17

  30. Vizi ES, Kobayashi O, Töröcsik A, Kinjo M, Nagashima H, Manabe N, Goldiner PL, Plotter PE, Foldes FF (1989) Heterogeneity of presynaptic muscarinic receptors involved in modulation or transmitter release. Neuroscience 31:259–267

  31. Zaborski L, Heimer L, Eckenstein F, Lernath C (1986) GABAergic input to cholinergic forebrain neurons: an ultrastructural study using retrograde tracing of HRP and double immunolabeling. J Comp Neurol 250:282–295

  32. Zsilla G, Cheney DL, Costa E (1976) Regional changes in the rats of turnover of acetylcholine in rat brain following diazepam or muscimol. Arch Pharmacol 294:251–255

Download references

Author information

Correspondence to Paavo Riekkinen Jr.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Riekkinen, P., Riekkinen, M., Sirviö, J. et al. Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing. Psychopharmacology 111, 195–201 (1993). https://doi.org/10.1007/BF02245523

Download citation

Key words

  • β-Carboline ZK 93426
  • Scopolamine
  • Mecamylamine
  • Nucleus basalis
  • Disinhibition
  • Neocortical EEG slowing